Obese women who carry most of their excess weight around the stomach are 70% more likely to develop pancreatic cancer, according to a study published on-line by the British Journal of Cancer.
A team of researchers followed over 138,000 post-menopausal women in the USA for over seven years to investigate the effects of obesity on pancreatic cancer as a part of the Women's Health Initiative. 251 women in the study developed pancreatic cancer. Of these, 78 were in the group with highest the waist-to-hip ratios. This is 70% more (after adjusting for other potential risk factors including age and smoking status) than the 34 women with the lowest waist-to-hip ratios who went on to develop the disease.
Lead author Juhua Luo, based at the Karolinska Institute in Sweden, said: "we found that the risk of developing pancreatic cancer was significantly raised in obese post-menopausal women who carry most of their excess weight around the stomach. Obesity is a growing and largely preventable problem, so it's important that women are aware of this major increase in risk."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze